Detecting diseases such as cancer in their earliest stages can make a huge difference in patient treatment, but it is often difficult to do. Now scientists report in the journal ACS Central Science a new, simple method that could make early disease diagnosis much easier. In addition, their approach only requires a minute sample of patient blood and is 1,000 times more sensitive in detecting biomarkers for thyroid cancer than the current government-approved test.
In response to a wide range of conditions, including cancer, viral infections and autoimmune disorders, the body’s immune system produces proteins called antibodies. Identifying specific antibodies can help physicians make accurate diagnoses. However, levels of these proteins are low at early disease stages, so it is difficult to detect them with methods currently approved by the U.S. Food and Drug Administration (FDA). Also, some of these tests involve hazardous radioactive materials and specialized facilities, making them expensive to carry out. Carolyn R. Bertozzi and colleagues wanted to come up with a simpler, more accessible approach that could detect low concentrations of these proteins.
The researchers developed a new way to detect antibodies in a fraction of a drop of blood with common lab equipment.
Testing it with patient samples showed that the method, called antibody detection by agglutination-PCR or ADAP, was 1,000 times more sensitive in detecting thyroid cancer antibodies than the radioimmunoassays that are the current gold standard. The researchers say ADAP could also be designed to look for antibodies in saliva.
The Latest on: Diagnosing diseases
via Google News
The Latest on: Diagnosing diseases
- 1st blood test to help diagnose Alzheimer’s disease goes on saleon December 1, 2020 at 4:46 am
A company has started selling the first blood test to help diagnose Alzheimer’s disease, a leap for the field that could make it much easier for people to learn whether they have dementia. It also ...
- New blood test aims to help diagnose Alzheimer's disease, but comes with a caveaton November 30, 2020 at 10:32 pm
The new test is not approved by the FDA and is not supported by the Alzheimer's Association. But advocates are encouraged by the research.
- Married At First Sight's Ines Basic jokes she has been 'diagnosed with mad cow disease'on November 30, 2020 at 9:50 pm
Ouch! Former Married At First Sight star Ines Basic was hospitalised this week after breaking her nose The Bosnian beauty then joked in the caption: 'Got diagnosed with mad cow disease. My doctor is ...
- New selective method for DNA sequencing could enable quicker diagnosis of rare diseaseson November 30, 2020 at 4:14 pm
Understanding the sequence of human DNA gives scientists information about diseases, including potentially how to diagnose or treat them.
- New tests identify very early changes in Alzheimer's disease before symptoms appearon November 30, 2020 at 1:29 pm
Researchers at the University of Gothenburg in Sweden, together with their colleagues at the Barcelona Beta Research Centre in Spain, the University Medical Centre in Ljubljana, Slovenia, and the ...
- Autoimmune Disease Diagnosis Market Forecast 2020-2029 : Strategic Industry Evolutionary Analysis | Thermo Fisher Scientific, Hoffmann-La Roche Ltdon November 30, 2020 at 1:28 pm
A consciously conceived and designed business intelligence report titled Global Autoimmune Disease Diagnosis market 2020 by Manufacturers, Type, and Application, Forecast to 2029 by MarketResearch.biz ...
- Sen. Chuck Grassley, 87, cleared by doctors to return to work following COVID-19 diagnosison November 30, 2020 at 10:11 am
"This disease affects people differently. I did not experience symptoms, but more than a thousand Americans are dying every day," Grassley said.
- AI model uses retinal scans to predict Alzheimer's diseaseon November 30, 2020 at 9:53 am
A form of artificial intelligence designed to interpret a combination of retinal images was able to successfully identify a group of patients who were known to have Alzheimer's disease, suggesting the ...
- First blood test to help diagnose Alzheimer's disease goes on saleon November 30, 2020 at 9:40 am
The test has not been approved by the U.S. Food and Drug Administration — it's being sold under more general rules for commercial labs.
- New DNA scanning method could lead to quicker diagnosis of cancer and rare diseaseon November 30, 2020 at 9:29 am
Understanding the sequence of human DNA gives scientists information about diseases, including potentially how to diagnose or treat them. In a new paper published in Nature Biotechnology, scientists ...
via Bing News